Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr488 Inhibitors

Olfr488, belonging to the G protein-coupled receptor (GPCR) family, plays a pivotal role in olfactory sensory perception by serving as a chemosensory receptor. Positioned on the cell membrane of olfactory sensory neurons, Olfr488 is tasked with the detection and transduction of specific odorant molecules, initiating signaling cascades that contribute to the complex landscape of olfactory sensation. The receptor's selectivity in recognizing distinct chemical stimuli highlights its significance in shaping an organism's olfactory experience, influencing behavioral responses based on environmental cues.

The inhibition of Olfr488 involves a sophisticated interplay of chemical modulators, each meticulously designed to target specific components within intracellular signaling pathways associated with this GPCR. These inhibitors act through diverse mechanisms, finely tuned to disrupt crucial cellular processes. Compounds impacting the MAPK pathway, for instance, exert their influence downstream, modulating elements such as SPRY4, leading to indirect inhibition of Olfr488. Pertussis Toxin interferes with G protein subunits, disrupting GPCR signaling and contributing to Olfr488 inhibition. Additionally, molecules altering intracellular calcium dynamics, like Thapsigargin and Thioridazine, influence calmodulin-associated cascades, indirectly impacting Olfr488 activity. Inhibition through the PI3K-AKT pathway, facilitated by compounds such as Wortmannin and LY294002, showcases the intricate nature of signaling modulation, ultimately influencing Olfr488 function. The diversity in mechanisms underscores the complexity of GPCR inhibition, offering valuable insights into potential avenues for further research in understanding olfactory transduction processes.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Multikinase inhibitor targeting RAF and VEGFR, indirectly impacting Olfr488 by disrupting downstream signaling cascades.

Pertussis Toxin (islet-activating protein)

70323-44-3sc-200837
50 µg
$451.00
3
(1)

Inhibits Gαi proteins, affecting GPCR signaling and leading to indirect inhibition of Olfr488.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Induces ER stress by inhibiting SERCA, triggering unfolded protein response (UPR) and influencing Olfr488 activity indirectly.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

PI3K inhibitor disrupting PI3K-AKT pathway, impacting downstream signaling and contributing to Olfr488 inhibition indirectly.

OG-L002

1357302-64-7sc-478221
5 mg
$270.00
(0)

Targets Rho kinase, modulating cytoskeletal dynamics and GPCR signaling, indirectly inhibiting Olfr488.

Thioridazine

50-52-2sc-473180
50 mg
$500.00
(0)

Alters intracellular calcium levels, influencing calmodulin-associated cascades, leading to indirect inhibition of Olfr488.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

Selective p38 MAPK inhibitor impacting downstream effectors, contributing to Olfr488 inhibition through the MAPK pathway indirectly.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$94.00
$227.00
30
(1)

Src family kinase inhibitor, disrupting downstream signaling pathways and contributing to Olfr488 inhibition indirectly.

KN-93

139298-40-1sc-202199
1 mg
$182.00
25
(1)

Calmodulin kinase II (CaMKII) inhibitor, influencing calmodulin-associated cascades, leading to indirect inhibition of Olfr488.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor disrupting PI3K-AKT pathway, impacting downstream signaling and contributing to Olfr488 inhibition indirectly.